New role uncovered for ‘oldest’ tumour suppressor gene- the retinoblastoma gene
26 March 2015 | By Victoria White
Scientists have revealed a brand new function for one of the first cancer genes ever discovered – the retinoblastoma gene...
List view / Grid view
26 March 2015 | By Victoria White
Scientists have revealed a brand new function for one of the first cancer genes ever discovered – the retinoblastoma gene...
26 March 2015 | By Victoria White
Taconic and Cellaria have entered into a scientific collaboration to facilitate use of patient-derived xenografts in animal models for oncology research...
19 March 2015 | By Victoria White
While chemotherapy remains the most important class of drugs for breast cancer treatment, the trend toward targeted therapies is on the rise...
19 March 2015 | By Victoria White
PARP inhibitors that target cancers with mutations in the BRCA breast cancer genes could also work against tumours with another type of genetic fault...
4 March 2015 | By The Institute of Cancer Research
Testing breast cancer cells for how closely they resemble stem cells could identify women with the most aggressive disease, a new study suggests...
4 March 2015 | By The Institute of Cancer Research
Changing the shape of breast cancer cells could make the disease more sensitive to treatments – even driving the body’s own inflammatory response against a tumour – a new study shows...
27 February 2015 | By The Institute of Cancer Research
Scientists have developed a new test which can predict the survival chances of women with breast cancer by analysing images of ‘hotspots’ where there has been a fierce immune reaction to a tumour...
5 February 2015 | By The Institute of Cancer Research
A worldwide study of the DNA of 100,000 women has discovered two new genetic variants associated with an increased risk of breast cancer...
4 February 2015 | By Frost & Sullivan
Ongoing research aims to develop oncologic imaging technologies that diagnose cancer at the cellular level before the disease manifests, finds Frost & Sullivan...
6 January 2015 | By The Institute of Cancer Research
An experimental cancer drug may block an important driver for the survival, growth and spread of cancer cells...
8 October 2014 | By The Wellcome Trust, The Institute of Cancer Research & Merck Serono
Merck Serono, The Institute of Cancer Research, and the Wellcome Trust, London, have announced a co-development and license agreement building on two independent research programs at both the ICR and Merck Serono to identify inhibitors of tankyrase, an enzyme of the poly (ADP-ribose) polymerase family...
The use of monoclonal antibodies and antibody-based molecules as therapeutics to treat patients suffering with severe disease has become a major success story. Due to the exquisite specificity with which they interact with their antigen and the fact that their large binding surface can intervene at sites and targets not…
29 September 2014 | By Caris Life Sciences
Caris Life Sciences announced important new data presented at the European Society for Medical Oncology Annual Conference, highlighting how tumour profiling with Caris Molecular Intelligence can help transform cancer care...
23 September 2014 | By The Institute of Cancer Research
Even long stretches of DNA that contain no genes at all can affect the risk of breast cancer, by physically interacting with genes elsewhere, a new study reports...
16 September 2014 | By Andrew Lloyd & Associates
Curie-Cancer and Inventiva announce the launch of the Epicure project, which has just received financial backing from France’s national research agency, the ANR...